PARIS & CAMBERLEY, England (BUSINESS WIRE) Regulatory News:Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s exsig™ COVID-19 Direct Real-Time PCR test has been approved in the UK under the UK Health Security Agency's Medical Devices (Coro.
The "Europe Organ Transplant Diagnostics Market 2021-2031 by Offering, Transplant, Application, Technology, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's
Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces a trading update for the half year ended 30 June 2022 and provides an update